Literature DB >> 14522957

How nerve growth factor drives physiological and inflammatory expressions of acid-sensing ion channel 3 in sensory neurons.

Julien Mamet1, Michel Lazdunski, Nicolas Voilley.   

Abstract

Nerve growth factor (NGF) is a key element of inflammatory pain. It induces hyperalgesia by up-regulating the transcription of genes encoding receptors, ion channels, and neuropeptides. Acid-sensing ion channel 3 (ASIC3), a depolarizing sodium channel gated by protons during tissue acidosis, is specifically expressed in sensory neurons. It has been associated to cardiac ischemic and inflammatory pains. We previously showed that low endogenous NGF was responsible for ASIC3 basal expression and high NGF during inflammation increased ASIC3 expression parallely to the development of neuron hyperexcitability associated with hyperalgesia. NGF is known to activate numerous signaling pathways through trkA and p75 receptors. We now show that (i). NGF controls ASIC3 basal expression through constitutive activation of a trkA/phospholipase C/protein kinase C pathway, (ii). high inflammatory-like NGF induces ASIC3 overexpression through a trkA/JNK/p38MAPK pathway and a p75-dependent mechanism as a transcriptional switch, and (iii). NGF acts through AP1 response elements in ASIC3 encoding gene promoter. These new data indicate potential targets that could be used to develop new treatments against inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522957     DOI: 10.1074/jbc.M309468200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons.

Authors:  Sylvie Diochot; Anne Baron; Lachlan D Rash; Emmanuel Deval; Pierre Escoubas; Sabine Scarzello; Miguel Salinas; Michel Lazdunski
Journal:  EMBO J       Date:  2004-03-25       Impact factor: 11.598

2.  Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential.

Authors:  Xiang-Ping Chu; Christopher J Papasian; John Q Wang; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-18

Review 3.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

Review 4.  Peripheral nerve injury modulates neurotrophin signaling in the peripheral and central nervous system.

Authors:  Mette Richner; Maj Ulrichsen; Siri Lander Elmegaard; Ruthe Dieu; Lone Tjener Pallesen; Christian Bjerggaard Vaegter
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  βENaC acts as a mechanosensor in renal vascular smooth muscle cells that contributes to renal myogenic blood flow regulation, protection from renal injury and hypertension.

Authors:  Heather A Drummond; David E Stec
Journal:  J Nephrol Res       Date:  2015-06-26

6.  ASIC3 contributes to the blunted muscle metaboreflex in heart failure.

Authors:  Jihong Xing; Jian Lu; Jianhua Li
Journal:  Med Sci Sports Exerc       Date:  2015-02       Impact factor: 5.411

7.  ASIC1 and ASIC3 play different roles in the development of Hyperalgesia after inflammatory muscle injury.

Authors:  Roxanne Y Walder; Lynn A Rasmussen; Jon D Rainier; Alan R Light; John A Wemmie; Kathleen A Sluka
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

Review 8.  The evolution of nerve growth factor inhibition in clinical medicine.

Authors:  Barton L Wise; Matthias F Seidel; Nancy E Lane
Journal:  Nat Rev Rheumatol       Date:  2020-11-20       Impact factor: 20.543

9.  Chemosensitivity and mechanosensitivity of nociceptors from incised rat hindpaw skin.

Authors:  Sinyoung Kang; Timothy J Brennan
Journal:  Anesthesiology       Date:  2009-07       Impact factor: 7.892

10.  Expression and function of proton-sensing G-protein-coupled receptors in inflammatory pain.

Authors:  Ying-Ju Chen; Chia-Wei Huang; Chih-Shin Lin; Wen-Han Chang; Wei-Hsin Sun
Journal:  Mol Pain       Date:  2009-07-14       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.